The opened vial of Bharat Biotech's coronavirus vaccine, Covaxin, can be stored at 2 to 8 degrees Celsius for up to 28 days. It is not required to be discarded immediately in a day or at the end of immunization session.
Covaxin 77.8% Per Cent Effective: Lancet
Covaxin is found to be 77.8% effective, reveal clinical trials. The vaccine maker Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%.
Covaxin is found to be 77.8% effective, reveal clinical trials. The vaccine maker Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%.
‘Each vial of Covaxin contains 20 doses. The vaccine is approved for use under the 28-day multi-dose vial policy from Drugs Controller General of India and the WHO Emergency Use Listing (WHO EUL).’
"We believe in being environmentally friendly by reducing the quantum of packing materials and single-use plastics that are utilised in vaccines manufacturing, storage, distribution and disposal," it added. The Central Drugs Standard Control Organisation (CDSCO) last month approved the extension of Covaxin's shelf life up to 12 months from the date of manufacture.
This approval of shelf-life extension is based on the availability of additional stability data, which was submitted to the CDSCO. With the shelf-life extension, hospitals can now utilise the stock which was nearing the expiry and avoid vaccine wastage, the vaccine-maker said.
Covaxin Gets WHO's Approval
Bharat Biotech's Covaxin has been granted Emergency Use Listing approval by the World Health Organisation (WHO).
Bharat Biotech's Covaxin has been granted Emergency Use Listing approval by the World Health Organisation (WHO).
India can Supply 5 Billion Covaxin Dosages to World
India continued to be a trusted partner in the context of reliable supply chains, the IT sector, the BPOs, despite the challenges faced during the pandemic.
India continued to be a trusted partner in the context of reliable supply chains, the IT sector, the BPOs, despite the challenges faced during the pandemic.
Covaxin Neutralizes Alpha and Delta Variants Effectively
Covaxin can effectively neutralize the Alpha (B117) and Delta (B1617) variants. Bharat Biotech developed Covaxin in collaboration with the ICMR-National Institute of Virology and over 700 million doses of Covaxin is gonna be produced by the end of 2021.
Covaxin can effectively neutralize the Alpha (B117) and Delta (B1617) variants. Bharat Biotech developed Covaxin in collaboration with the ICMR-National Institute of Virology and over 700 million doses of Covaxin is gonna be produced by the end of 2021.
